News

mRNA vaccines modified to include cytokine IL-12 enhance T cell response
In the quest to design vaccines that better help the body's immune system fight disease, scientists are always looking for ...
Bolt Biotherapeutics, Inc.: Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
BDC-4182 Phase 1 dose-escalation study now open for enrollmentBDC-3042 Phase 1 dose-escalation data presented at AACR 2025 demonstrated a favorable safety profile, dose-dependent biological activity ...
Healio15h
Osteoarthritis drawing ‘long overdue’ excitement, but disease modification still elusive
Although osteoarthritis is receiving more attention in both the research and clinical arenas than ever, all that attention ...